PD-1 blockade reprograms antiviral immunity and reduces the HIV reservoir - Nature

PD-1 blockade reprograms antiviral immunity and reduces the HIV reservoir  Nature

Innate antiviral and immune functions associated with the HIV reservoir decay after anti-PD-1 the...

Innate antiviral and immune functions associated with the HIV reservoir decay after anti-PD-1 therapy  Nature

A Hidden Defense Inside Llamas Could Be The Secret to Fighting HIV - ScienceAlert

A Hidden Defense Inside Llamas Could Be The Secret to Fighting HIV  ScienceAlert

London patient remains HIV-free after 2.5 years off treatment - Aidsmap

London patient remains HIV-free after 2.5 years off treatment  Aidsmap

Six-country study shows dolutegravir-based treatment is highly effective in children and adolesce...

Six-country study shows dolutegravir-based treatment is highly effective in children and adolescents  Aidsmap

Scientists use gene-edited stem cells to treat HIV — with mixed success - Nature

Scientists use gene-edited stem cells to treat HIV — with mixed success  Nature

People with HIV gain weight faster than HIV-negative people - Aidsmap

People with HIV gain weight faster than HIV-negative people  Aidsmap

Deep sequencing of HIV-1 reverse transcripts reveals the multifaceted antiviral functions of APOB...

Deep sequencing of HIV-1 reverse transcripts reveals the multifaceted antiviral functions of APOBEC3G  Nature

Therapeutic vaccine shows potential for HIV control off treatment in early study - Aidsmap

Therapeutic vaccine shows potential for HIV control off treatment in early study  Aidsmap

Child with HIV maintains viral suppression for three years off treatment - Aidsmap

Child with HIV maintains viral suppression for three years off treatment  Aidsmap

Experts shed light on coronavirus response and its implications for people with HIV - Aidsmap

Experts shed light on coronavirus response and its implications for people with HIV  Aidsmap

African studies show that lowering viral load in the community reduces HIV incidence, but is not ...

African studies show that lowering viral load in the community reduces HIV incidence, but is not enough to eliminate HIV  Aidsmap

“If we don’t include women in trials, we are not protecting women” – dolutegravir in pregnant wom...

“If we don’t include women in trials, we are not protecting women” – dolutegravir in pregnant women living with HIV  Aidsmap

Earlier treatment and higher CD4 counts linked to smaller HIV reservoir - Aidsmap

Earlier treatment and higher CD4 counts linked to smaller HIV reservoir  Aidsmap

Home tests aren’t an accurate way for people on HIV treatment to check they still have HIV - Aidsmap

Home tests aren’t an accurate way for people on HIV treatment to check they still have HIV  Aidsmap

HIV incidence fell by three-quarters in Australian gay men, with strong association with treatmen...

HIV incidence fell by three-quarters in Australian gay men, with strong association with treatment as prevention  Aidsmap

Long-acting injectable treatment maintains viral suppression - Aidsmap

Long-acting injectable treatment maintains viral suppression  Aidsmap

COVID-19 pandemic has speeded up the implementation of multi-month dispensing - Aidsmap

COVID-19 pandemic has speeded up the implementation of multi-month dispensing  Aidsmap

Weight gain on HIV treatment: drug combinations, not single drugs, need to be focus of quest for ...

Weight gain on HIV treatment: drug combinations, not single drugs, need to be focus of quest for cause  Aidsmap

Two PEP doses spaced a week apart protect monkeys from injected HIV; one dose might work in human...

Two PEP doses spaced a week apart protect monkeys from injected HIV; one dose might work in humans  Aidsmap

Progress on 90-90-90 HIV targets shows stark gap between eastern and western Europe - Aidsmap

Progress on 90-90-90 HIV targets shows stark gap between eastern and western Europe  Aidsmap

Opportunistic infections remain common in people taking HIV treatment in Latin America - Aidsmap

Opportunistic infections remain common in people taking HIV treatment in Latin America  Aidsmap

Poor adherence associated with disruptive life events in young people living with HIV - Aidsmap

Poor adherence associated with disruptive life events in young people living with HIV  Aidsmap

Every-other-month injectable cabotegravir and rilpivirine suppresses viral load for two years - A...

Every-other-month injectable cabotegravir and rilpivirine suppresses viral load for two years  Aidsmap

Dolutegravir-based HIV treatment is the safest and most effective choice for pregnant women - Aid...

Dolutegravir-based HIV treatment is the safest and most effective choice for pregnant women  Aidsmap

Human Immunodeficiency Virus (HIV) Treatment Market Size, 2034 - Fortune Business Insights

Human Immunodeficiency Virus (HIV) Treatment Market Size, 2034  Fortune Business Insights

Luc Montagnier, co-discoverer of HIV, dies aged 89 - BBC

Luc Montagnier, co-discoverer of HIV, dies aged 89  BBC

Options for two-drug simplification expand - Aidsmap

Options for two-drug simplification expand  Aidsmap

Hepatitis C virtually eliminated in people with HIV in the Netherlands - Aidsmap

Hepatitis C virtually eliminated in people with HIV in the Netherlands  Aidsmap

Antiviral Drugs Market Size, Share, Growth, Forecast, 2034 - Fortune Business Insights

Antiviral Drugs Market Size, Share, Growth, Forecast, 2034  Fortune Business Insights